-
AstraZeneca’s oncology treatments granted accelerated access through Ontario’s FAST Program
23 Jan 2026 22:21 GMT
… untreated mantle cell lymphoma. MISSISSAUGA — AstraZeneca Canada announced on Jan. 23 … medicines,” said Gaby Bourbara, President, AstraZeneca Canada. “Public funding of Tagrisso …
-
Daiichi Sankyo and AstraZeneca’s Enhertu gains NMPA approval for HER2 GEJ
23 Jan 2026 12:15 GMT
Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has … Sankyo and jointly developed with AstraZeneca.
The approval is supported by … September 2025, Daiichi Sankyo and AstraZeneca received priority review from the …
-
AstraZeneca Acquires AI Startup Modella to Accelerate Oncology Drug Development
23 Jan 2026 00:25 GMT
… J.P. Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin … acquisition would "supercharge" AstraZeneca's efforts in quantitative … . Sarin said Modella will help AstraZeneca develop "highly targeted biomarkers …
-
AstraZeneca Secures Full Global Rights to AbelZeta’s C-CAR031
22 Jan 2026 20:45 GMT
… the companies’ prior agreement.
Previously, AstraZeneca already held the rights to … . The therapy is designed using AstraZeneca’s proprietary dominant negative transforming … milestone payments and royalties.
For AstraZeneca, the deal reinforces its commitment …
-
Controversial AstraZeneca vaccine remained in use despite thousands of heart condition reports to drug regulator
21 Jan 2026 16:23 GMT
… fears grew around the AstraZeneca (AZ) vaccine after it … been taken.
The Oxford-AstraZeneca Covid vaccine was withdrawn … side effects from the AstraZeneca jab are “extremely rare … In May last year, AstraZeneca voluntarily withdrew its marketing authorisation …
-
AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M
21 Jan 2026 13:48 GMT
…
January 21, 2026 | Wednesday | News
AstraZeneca owns the development, manufacturing and … therapeutic products, has announced that AstraZeneca has agreed to acquire AbelZeta … a prior agreement with AbelZeta, AstraZeneca owns the development, manufacturing and …
-
AstraZeneca-Modella AI Acquisition to Speed Oncology R&D
21 Jan 2026 08:55 GMT
… development and biomarker discovery. The AstraZeneca-Modella AI acquisition expands a … J.P. Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin … targeted biomarkers and therapies. The AstraZeneca-Modella AI acquisition also allows …
-
Astrazeneca expands China cell therapy footprint with Abelzeta CAR T
20 Jan 2026 20:08 GMT
Astrazeneca plc is paying up to $ …
-
AstraZeneca says US listing starts February
20 Jan 2026 17:43 GMT
… :27
British pharmaceutical giant AstraZeneca on Tuesday said trading of … towards the United States.
AstraZeneca had announced in September plans … tier FTSE 100 index.
AstraZeneca said Tuesday that its New … is a part of AstraZeneca’s shareholder approved plan …
-
AstraZeneca pays $630m to get full control of AbelZeta CAR-T
20 Jan 2026 17:27 GMT
AstraZeneca's push into CAR- …
About
© 1995-2026